Biotech | May 02, 2022
Xcardia announces first-in-human use of its new Xtractor device
The announcement follows FDA 510(k) clearance of device
The announcement follows FDA 510(k) clearance of device
Blood test for early detection of Alzheimer's Disease (AD) risk will lead to better patient care, physicians say; US. adults call for earlier evaluation and more education
Move brings together AstraZeneca and Alexion colleagues in a purpose-built facility in Kendall Square, Cambridge, MA, a world-leading life sciences hub
Flagship U.S. facility will include biologic manufacturing and late stage research and clinical development of innovative cancer medicines
Pharma exports in 2021-22 sustain a positive growth despite global trade disruptions
Center of Excellence for Molecular Diagnostics and Proteomics will enable affordable diagnostics for infectious diseases in India
Ultomiris showed early effect and lasting improvement in activities of daily living and has potential to reduce treatment burden with dosing every 8 weeks
South Carolina’s largest health system adopts Philips software solutions for patient monitoring and enterprise imaging, helping to drive interoperability and data analytics, and deliver on Quadruple Aim
Glenmark Pharmaceuticals won Innovation of the Year award
This facility will design & develop instruments, perform product reliability performance testing and verification
Subscribe To Our Newsletter & Stay Updated
